Food and Drug Administration, U.S. Department of Health and Human Services - October 9, 1991
Brad Stone; (301) 443-3285
HHS Secretary Louis W. Sullivan, M.D., today announced the Food and Drug Administration s approval of dideoxyinosine (DDI) -- an antiretroviral drug -- for treating patients at advanced stages of infection with the AIDS virus. DDI is approved for use in adult and pediatric AIDS patients who are intolerant to or whose h
Food and Drug Administration, U.S. Department of Health and Human Services - September 27, 1991
Karen Malone - (301) 443-3285
HHS Secretary Louis W. Sullivan, M.D., today announced the Food and Drug Administration s approval of the drug foscarnet for the treatment of AIDS patients with cytomegalovirus ( CMV ) retinitis. CMV retinitis is an eye infection that can lead to blindness in individuals with impaired immune systems.
Food & Drug Administration, U.S. Department of Health and Human Services - January 3, 1991
Pat Dorsey--(301) 443-3285
The Food and Drug Administration today announced approval of a new, purified blood clotting agent for people who suffer from hemophilia B, a genetic blood deficiency that causes uncontrollable bleeding. The product, called Coagulation Factor IX (Human), is an extract of human plasma.
Food and Drug Administration, U.S. Department of Health and Human Services - January 2, 1991
Brad Stone - (301) 443-3285
The Food and Drug Administration has approved Epoetin alfa, a genetically engineered form of the protein erythropoietin, to treat the anemia that some patients with AIDS or patients who are at earlier stages of infection with the AIDS virus experience while taking zidovudine, commonly called